Back to Search
Start Over
Inhibition of HIV-1 by an anti-integrase single-chain variable fragment (SFv): delivery by SV40 provides durable protection against HIV-1 and does not require selection.
- Source :
-
Gene therapy [Gene Ther] 1999 Apr; Vol. 6 (4), pp. 660-6. - Publication Year :
- 1999
-
Abstract
- Human immunodeficiency virus type 1 (HIV-1) encodes several proteins that are packaged into virus particles. Integrase (IN) is an essential retroviral enzyme, which has been a target for developing agents to inhibit virus replication. In previous studies, we showed that intracellular expression of single-chain variable antibody fragments (SFvs) that bind IN, delivered via retroviral expression vectors, provided resistance to productive HIV-1 infection in T-lymphocytic cells. In the current studies, we evaluated simian-virus 40 (SV40) as a delivery vehicle for anti-IN therapy of HIV-1 infection. Prior work suggested that delivery using SV40 might provide a high enough level of transduction that selection of transduced cells might be unnecessary. In these studies, an SV40 expression vector was developed to deliver SFv-IN (SV(Aw)). Expression of the SFv-IN was confirmed by Western blotting and immunofluorescence staining, which showed that > 90% of SupT1 T-lymphocytic cells treated with SV(Aw) expressed the SFv-IN protein without selection. When challenged, HIV-1 replication, as measured by HIV-1 p24 antigen expression and syncytium formation, was potently inhibited in cells expressing SV40-delivered SFv-IN. Levels of inhibition of HIV-1 infection achieved using this approach were comparable to those achieved using murine leukemia virus (MLV) as a transduction vector, the major difference being that transduction using SV40 did not require selection in culture whereas transduction with MLV did require selection. Therefore, the SV40 vector as gene delivery system represents a novel therapeutic strategy for gene therapy to target HIV-1 proteins and interfere with HIV-1 replication.
- Subjects :
- Blotting, Western
Cells, Cultured
HIV Integrase analysis
HIV Integrase immunology
Humans
Immunoglobulin Fragments administration & dosage
Immunoglobulin Fragments immunology
Leukemia Virus, Murine genetics
T-Lymphocytes immunology
Transfection methods
Virus Replication
Genetic Therapy methods
Genetic Vectors administration & dosage
HIV Infections therapy
HIV-1
Simian virus 40 genetics
Subjects
Details
- Language :
- English
- ISSN :
- 0969-7128
- Volume :
- 6
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Gene therapy
- Publication Type :
- Academic Journal
- Accession number :
- 10476226
- Full Text :
- https://doi.org/10.1038/sj.gt.3300864